Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : PHARMACEUTICALS
LUPIN LTD.
Lupin Ltd.
NSE: LUPIN | BSE: 500257
Mid-range Performer
In 2 Starfolio Baskets
Download real time
2082.20
10.80
(
0.52
%)
852.5K
NSE+BSE Volume
NSE
28 Nov, 2025 3:31 PM (IST)
Watchlist
Portfolio
Alert
My Notes
TRADE STOCK
Analyst Upgrade
Geojit BNP Paribas upgrades Lupin to a 'Buy' call, expects a revenue CAGR of 10.2% over FY26-27
See details
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Lupin Alerts
Lupin Price Alerts, Volume, SMA/EMA, and new research reports alerts.
Get real time alert for Lupin. Alerts are delivered to your email. You can configure alerts for price, SMA and volume changes, as well as for new research reports.
Is Lupin Ltd. worth buying?
931 Votes:
Buy
72.72%
Sell
17.62%
Hold
9.67%
BUY
SELL
HOLD
RESEARCH REPORTS
Buy
SEE REPORTS >
25 Nov 2025
pdf
Lupin Ltd.
by Geojit BNP Paribas
| Target:
2225
| Upside:
6.86%
Buy
SEE REPORTS >
13 Nov 2025
pdf
Lupin Ltd.
by Deven Choksey
| Target:
2404
| Upside:
15.45%
All reports of LUPIN